DD · DuPont de Nemours, Inc.
Price & Indicators
Raw chart and full-history price indicators begin at the captured split on Jun 24, 2026; bars on opposite sides are not compared.
The closing range begins at the captured split on Jun 24, 2026.
Up next
AI Brief
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders SellIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EPS non-GAAP | $1.88 | 2Q'26 | — |
|
|
|||
| Adjusted free cash flow non-GAAP | $454M | Six Months Ended Jun 30, 2026 | — |
|
|
|||
| Adjusted free cash flow conversion non-GAAP | 94% | Six Months Ended Jun 30, 2026 | — |
|
|
|||
| Operating EBITDA non-GAAP | $862M | Six Months Ended Jun 30, 2026 | — |
|
|
|||
| Organic sales non-GAAP | 4% | 2Q'26 | — |
|
|
|||
| Transaction-adjusted free cash flow non-GAAP | $473M | Six Months Ended Jun 30, 2026 | — |
|
|
|||
| Transaction-adjusted free cash flow conversion non-GAAP | 98% | Six Months Ended Jun 30, 2026 | — |
|
|
|||
| Adjusted earnings (non-GAAP) non-GAAP | 226M | Three Months Ended March 31, 2026 | — |
| Operating EBITDA margin non-GAAP | 24.6% | 1Q'26 | — |
|
|
|||
| Operating EBITDA - Diversified Industrials non-GAAP | $197M | Three Months Ended Dec 31, 2025 | — |
| Operating EBITDA - Healthcare & Water Technologies non-GAAP | $255M | Three Months Ended Dec 31, 2025 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Specialty Chemicals — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
DD
this stock
DuPont de Nemours, Inc.
|
$18.74B | — | -7.1% | 308.4 | 2.8% |
|
LIN
Linde PLC
|
$223.74B | +13.8% | +3.0% | 31.3 | 1.1% |
|
AIQUF
L Air Liquide SA /Fi
|
$124.58B | +4.4% | — | — | 0.0% |
|
SHW
Sherwin Williams Co
|
$84.64B | +6.5% | +2.1% | 32.2 | 2.6% |
|
ECL
Ecolab Inc.
|
$80.15B | +8.9% | +2.2% | 38.4 | 1.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
Raw-price comparisons begin at the captured split on Jun 24, 2026; windows that need an earlier baseline remain unavailable.
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| DD | +0.3% | 0.0% | — | +1.3% | — |
| SPY | +1.1% | +4.0% | +14.7% | +3.2% | +13.1% |
| vs SPY | -0.9% | -4.0% | — | -1.9% | — |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.